2008Chinese Journal of Hospital PharmacyRequires access

Pharmacokinetics of amlodipine besylate/atorvastatin calcium combination tablet in healthy volunteers

Xiaoyu Wang

Open publisher page 1 citations

Abstract

OBJECTIVE To study the pharmacokinetics of combination tablets containing amlodipine besylate/atorvastatin calcium in healthy volunteers.METHODS Thirty healthy volunteers(half male-half female)were divided into three groups.Each ten volunteers received a different dose strengths combination tablets(amlodipine/atorvastatin 5 mg/ 10 mg,10 mg/ 10 mg,5 mg/ 20 mg),respectively.The plasma concentrations of amlodipine and atorvastatin were measured by a fully validated LC-MS/MS method.The pharmacokinetic parameters were calculated thereafter in order to study the pharmacokinetic charateristics of amlodipine and atorvastatin in human.RESULTS The following data were the main pharmacokinetic parameters.Amlodipine(5 mg/ 10 mg),Cmax(3.14±0.46)μg·L-1,AUC0-120(131±22);10 mg/10 mg,Cmax(6.85±1.17)μg·L-1,AUC0-120(327±110)μg·h·L-1;5 mg/ 20 mg,Cmax(3.11±0.47)μg·L-1,AUC0-120(130±16)μg·h·L-1;atorvastatin,5 mg/10 mg,Cmax(11.3±6.7)nμg·L-1,AUC0-120(133.8±93.3);10 mg/10 mg,Cmax(16.7±12.1)μg·mL-1,AUC0-120(107.7±60.4)μg·h·L-1;5 mg/20 mg,Cmax(15.0±9.4)μg·L-1,AUC0-120(147.3±59.3)μg·h·L-1.CONCLUSION In all the three dose groups,Cmax and AUC of amlodipine increased in a dose-dependent manner.Atorvastatin coincide with non-linear pharmacokinetic characteristics.

About this research paper

What this paper is about

OBJECTIVE To study the pharmacokinetics of combination tablets containing amlodipine besylate/atorvastatin calcium in healthy volunteers.METHODS Thirty healthy volunteers(half male-half female)were divided into three groups.Each ten volunteers received a different dose strengths combination tablets(amlodipine/atorvastatin 5 mg/ 10 mg,10 mg/ 10 mg,5 mg/ 20 mg),respectively.The plasma concentrations of amlodipine and atorvastatin were measured by a fully validated LC-MS/MS method.The pharmacokinetic parameters were calculated thereafter in order to study the pharmacokinetic charateristics of amlodipine and atorvastatin in human.RESULTS The following data were the main pharmacokinetic parameters.Amlodipine(5 mg/ 10 mg),Cmax(3.14±0.46)μg·L-1,AUC0-120(131±22);10 mg/10 mg,Cmax(6.85±1.17)μg·L-1,AUC0-120(327±110)μg·h·L-1;5 mg/ 20 mg,Cmax(3.11±0.47)μg·L-1,AUC0-120(130±16)μg·h·L-1;atorvastatin,5 mg/10 mg,Cmax(11.3±6.7)nμg·L-1,AUC0-120(133.8±93.3);10 mg/10 mg,Cmax(16.7±12.1)μg·mL-1,AUC0-120(107.7±60.4)μg·h·L-1;5 mg/20 mg,Cmax(15.0±9.4)μg·L-1,AUC0-120(147.3±59.3)μg·h·L-1.CONCLUSION In all the three dose groups,Cmax and AUC of amlodipine increased in a dose-dependent manner.Atorvastatin coincide with non-linear pharmacokinetic characteristics.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the pharmacokinetics of combination tablets containing amlodipine besylate/atorvastatin calcium in healthy volunteers.METHODS Thirty healthy volunteers(half male-half female)were divided into three groups.Each ten volunteers received a different dose strengths combination tablets(amlodipine/atorvastatin 5 mg/ 10 mg,10 mg/ 10 mg,5 mg/ 20 mg),respectively.The plasma concentrations of amlodipine and atorvastatin were measured by a fully validated LC-MS/MS method.The pharmacokinetic parameters were calculated thereafter in order to study the pharmacokinetic charateristics of amlodipine and atorvastatin in human.RESULTS The following data were the main pharmacokinetic parameters.Amlodipine(5 mg/ 10 mg),Cmax(3.14±0.46)μg·L-1,AUC0-120(131±22);10 mg/10 mg,Cmax(6.85±1.17)μg·L-1,AUC0-120(327±110)μg·h·L-1;5 mg/ 20 mg,Cmax(3.11±0.47)μg·L-1,AUC0-120(130±16)μg·h·L-1;atorvastatin,5 mg/10 mg,Cmax(11.3±6.7)nμg·L-1,AUC0-120(133.8±93.3);10 mg/10 mg,Cmax(16.7±12.1)μg·mL-1,AUC0-120(107.7±60.4)μg·h·L-1;5 mg/20 mg,Cmax(15.0±9.4)μg·L-1,AUC0-120(147.3±59.3)μg·h·L-1.CONCLUSION In all the three dose groups,Cmax and AUC of amlodipine increased in a dose-dependent manner.Atorvastatin coincide with non-linear pharmacokinetic characteristics.

Key concepts: Cmax, Amlodipine, Pharmacokinetics, Atorvastatin, Pharmacology, Chemistry, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of amlodipine besylate/atorvastatin calcium combination tablet in healthy volunteers — Research Paper | ScholarLens